Rentokil Initial (LON:RTO) Reaches New 52-Week Low – Time to Sell?

Rentokil Initial plc (LON:RTOGet Free Report) shares hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as GBX 315.30 ($4.09) and last traded at GBX 320 ($4.15), with a volume of 10226604 shares changing hands. The stock had previously closed at GBX 323.40 ($4.19).

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on RTO. JPMorgan Chase & Co. cut their price target on Rentokil Initial from GBX 440 ($5.71) to GBX 430 ($5.58) and set a “neutral” rating on the stock in a research note on Tuesday, January 14th. Deutsche Bank Aktiengesellschaft cut their price target on Rentokil Initial from GBX 485 ($6.29) to GBX 465 ($6.03) and set a “buy” rating on the stock in a research note on Friday, March 7th.

View Our Latest Report on Rentokil Initial

Rentokil Initial Stock Down 1.1 %

The business has a fifty day moving average of GBX 388.76 and a 200 day moving average of GBX 403.38. The firm has a market cap of £8.02 billion, a P/E ratio of 20.53, a P/E/G ratio of 0.56 and a beta of 0.55. The company has a quick ratio of 1.76, a current ratio of 1.04 and a debt-to-equity ratio of 113.35.

Rentokil Initial (LON:RTOGet Free Report) last released its quarterly earnings data on Thursday, March 6th. The company reported GBX 21.25 ($0.28) EPS for the quarter. Rentokil Initial had a return on equity of 9.50% and a net margin of 7.25%. On average, equities research analysts predict that Rentokil Initial plc will post 25.8725561 EPS for the current year.

About Rentokil Initial

(Get Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

Further Reading

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.